XML 17 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814

NATURE OF OPERATIONS AND BASIS OF PRESENTATION (Detail Textuals) - Biomedical catalyst of United Kingdom government $ in Millions	9 Months Ended
	Sep. 30, 2015 USD ($)
NSCLC and Nasopharyngeal Cancer
Organization [Line Items]
Grant award amount	$ 1.9
Investigational new drug (IND)
Organization [Line Items]
Grant award amount	$ 3.5

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	cycc_OrganizationLineItems
Namespace Prefix:	cycc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Cash received from grantors during the current period related to operating activities. This element represents receipts from a guarantor for the amount of guarantee provided.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef



-Publisher FASB



-Name Accounting Standards Codification



-Topic 230



-SubTopic 10



-Section 45



-Paragraph 25



-Subparagraph (c)



-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name:	us-gaap_ProceedsFromGrantors
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	cycc_GrantAwardeeAxis=cycc_BiomedicalCatalystOfUnitedKingdomGovernmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cycc_ProgramAxis=cycc_NsclcAndNasopharyngealCancerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cycc_ProgramAxis=cycc_InvestigationalNewDrugMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: